These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
55 related items for PubMed ID: 3780392
1. [The preparation of antihuman apolipoprotein B antisera and its clinical application]. Zhou X, Zhang HZ, Yin YL. Zhonghua Xin Xue Guan Bing Za Zhi; 1986 Jun; 14(3):135-7, 190. PubMed ID: 3780392 [No Abstract] [Full Text] [Related]
2. Laboratory parameters as discriminators for peripheral atherosclerosis and stroke. Kostner GM, Marth E, Pfeiffer KH, Wege H. Monogr Atheroscler; 1986 Jun; 14():119-23. PubMed ID: 3736549 [No Abstract] [Full Text] [Related]
3. [Studies of thrombophilic syndromes. I. Coagulation changes in coronary arteriosclerosis, cerebral arteriosclerosis and peripheral artery arteriosclerosis]. Neri Serneri GG, Paoletti P, Silvestrini E, Masotti G. Riv Crit Clin Med; 1968 Jun; 68(3):211-37. PubMed ID: 5737876 [No Abstract] [Full Text] [Related]
4. [Studies of thrombophilic syndromes. II. Preliminary research on the behavior of the plasmatic inhibitor of the product of the contact reaction in coronary, cerebral and peripheral arteriosclerosis]. Neri Serneri GG, Paoletti P, Silvestrini E, Masotti G. Riv Crit Clin Med; 1968 Jun; 68(4):289-323. PubMed ID: 5746286 [No Abstract] [Full Text] [Related]
13. [Apolipoprotein B, a risk factor in ischemic heart disease: possibilities of its determination using Czechoslovak-manufactured antisera]. Ceska R, Sobra J, Kvasilová M, Procházková R. Sb Lek; 1989 Nov; 91(11-12):334-8. PubMed ID: 2626671 [Abstract] [Full Text] [Related]
14. [The effect of Halidor on serum lipid fractions in patients with coronary disease and cerebrovascular sclerosis]. Krámer M, Keller L, Molnár G. Orv Hetil; 1968 May 26; 109(21):Suppl:42-3. PubMed ID: 5720723 [No Abstract] [Full Text] [Related]
15. [Phenotyping of hyperlipoproteinemias in atherosclerosis patients treated at Kislovodsk]. Shumskaia VI. Vopr Kurortol Fizioter Lech Fiz Kult; 1978 May 26; (3):33-6. PubMed ID: 149419 [No Abstract] [Full Text] [Related]
16. Relationships between serum levels of autoantibodies against oxidized low density lipoproteins, lipid-soluble antioxidants and apolipoprotein B in patients with coronary heart disease. Bakalova RA, Hadzhimitova V, Ribarov S. Gen Physiol Biophys; 2000 Mar 26; 19(1):103-13. PubMed ID: 10930142 [Abstract] [Full Text] [Related]
17. Lipid and apolipoprotein levels in patients with ischaemic heart disease. A comparative study in Plzen and Moscow. Steinerová A, Perova NV, Metel'skaya VA, Topolcan O, Karlícek V, Polívková V. Cor Vasa; 1989 Mar 26; 31(4):257-63. PubMed ID: 2509134 [Abstract] [Full Text] [Related]
18. [Comparative study of blood lipids in coronary sclerosis and cerebrosclerosis]. Keller L, Fischer J, Farádi A. Orv Hetil; 1974 Jun 09; 115(23):1323-7. PubMed ID: 4840692 [No Abstract] [Full Text] [Related]
19. Serum haptoglobin level in atherosclerosis. Székely J, Simon A, Horváth E. Acta Med Acad Sci Hung; 1971 Jun 09; 28(1):19-26. PubMed ID: 5133496 [No Abstract] [Full Text] [Related]
20. [Relations between the degree of arteriosclerosis and trace element and lipid parameters]. Voigt H, Reuter W, Peters HJ, Köhler H, Herrmann W. Z Gesamte Hyg; 1984 Jun 09; 30(6):321-2. PubMed ID: 6475156 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]